ETNB
89Bio Inc
Price:  
8.04 
USD
Volume:  
518,527.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

89Bio WACC - Weighted Average Cost of Capital

The WACC of 89Bio Inc (ETNB) is 9.9%.

The Cost of Equity of 89Bio Inc (ETNB) is 10.00%.
The Cost of Debt of 89Bio Inc (ETNB) is 5.00%.

Range Selected
Cost of equity 8.20% - 11.80% 10.00%
Tax rate 0.10% - 0.30% 0.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.2% - 11.6% 9.9%
WACC

89Bio WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.95 1.23
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 11.80%
Tax rate 0.10% 0.30%
Debt/Equity ratio 0.03 0.03
Cost of debt 5.00% 5.00%
After-tax WACC 8.2% 11.6%
Selected WACC 9.9%